Business Context and Reporting Period
Company: Community Health Systems, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 30, 2017
Event: Entry into a Material Definitive Agreement regarding a Loan Modification.
Key Financial Metrics and Debt Structure
This filing details a modification to the Company's existing credit facility rather than reporting operational financial results (revenue, profit, or cash flow) for a specific period.
- Revolving Credit Facility: $1.0 billion total facility.
- Modified Commitment: $739 million portion of the commitments was extended.
- Termination Date Extension: Extended from January 27, 2019, to January 27, 2021 for the $739 million portion.
- Administrative Agent: Credit Suisse AG.
Material Changes Versus Prior Period
The primary material change is the amendment of the Credit Agreement dated July 25, 2007 (as previously amended). Key changes include:
- Term Extension: The maturity date for a significant portion of the revolving credit facility was pushed back by two years.
- Covenant Adjustments: Financial covenants regarding the maximum secured net leverage ratio and interest coverage ratio were amended with new thresholds and timelines.
Guidance, Outlook, and Covenants
The filing outlines specific financial covenants the Company must adhere to under the new agreement:
Secured Net Leverage Ratio
- April 1, 2017 – December 31, 2019: Maximum 4.50 to 1.00.
- January 1, 2020 – September 30, 2020: Maximum 4.25 to 1.00.
- Thereafter: Maximum 4.00 to 1.00.
Interest Coverage Ratio
- Through December 31, 2017: Minimum 1.75 to 1.00.
- Thereafter: Minimum 2.00 to 1.00.
Management Commentary: The filing contains no forward-looking guidance on revenue or earnings, focusing solely on the terms of the debt modification.
Investor Verification Checklist
- Verify the Company's current secured net leverage ratio to ensure compliance with the new 4.50:1.00 cap effective April 1, 2017.
- Confirm the Company's interest coverage ratio meets the 1.75:1.00 threshold required through the end of 2017.
- Review the full text of the Loan Modification Agreement (Exhibit 10.1) for additional covenants not summarized in the 8-K.
- Assess the impact of the reduced aggregate commitments ($739 million) on the Company's overall liquidity and borrowing capacity.